Post-transcriptional regulation of human microsomal epoxide hydrolase

Pharmacogenetics

Volumn 8, Issue 2, 1998, Pages 157-167

  Laurenzana, Elizabeth M ^a   Hassett, Christopher ^a   Omiecinski, Curtis J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Gene regulation; Human; Microsomal epoxide hydrolase

Indexed keywords

EPOXIDE HYDROLASE;

ALLELE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC POLYMORPHISM; HUMAN; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; PROTEIN SYNTHESIS; TRANSLATION REGULATION;

EID: 0031981574     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199804000-00008     Document Type: Article

References (38)

1. Antecol MH, Darveau A, Sonenberg N, Mukherjee BB. Altered biochemical properties of actin in normal skin fibroblasts from individuals predisposed to dominantly inherited cancers. Cancer Res 1986; 46:11867-11873.
2. Bentley P, Schmassmann H, Sims P, Oesch F. Epoxides derived from various polycyclic hydrocarbons as substrates of homogeneous and microsome-bound epoxide hydrolase. A general assay and kinetic properties. Eur J Biochem 1976; 69:97-103.
3. Bentley P, Oesch F, Glatt H. Dual role of epoxide hydratase in both activation and inactivation of benzo(a)pyrene. Arch Toxicol 1977; 39:65-75.
4. Buehler BA, Delimont D, van Waes M, Finnell RH. Prenatal prediction of risk of the fetal hydantoin syndrome. N Engl J Med 1990; 322:1567-1572.
5. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
6. Cresteil T, Beaune P, Kremers P, Celier C, Guengerich FP, Leroux JP. Immunoquantification of epoxide hydrolase and cytochrome P-450 isozymes in fetal and adult human liver microsomes. Eur J Biochem 1985; 151:345-350.
7. Faletto MB, Linko P, Goldstein JA. A single amino acid mutation (Ser180 (Cys) determines the polymorphism in cytochrome P450g (P4502C13) by altering protein stability. J Biol Chem 1992; 267:2032-2037.
8. Feigner PL, Gadek TR, Holm M, Roman R, Chan HW et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987: 7413-7417.
9. Gaedigk A, Spielberg SP, Grant DM. Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions. Pharmacogenetics 1994; 4:142-153.
10. Gallie DR. The cap and poly(A) tail function synergistically to regulate mRNA translational efficiency. Genes Dev 1991; 5:2108-2116.
11. Green VJ, Pirmohamed M, Kitteringham NR, Gaedigk A, Grant DM, Boxer M et al. Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity. Biochem Pharmacol 1995; 50:1353-1359.
12. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 1994; 3:421-428.
13. Hassett C, Lin J, Carty CL, Laurenzana EM, Omiecinski CJ. Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. Arch Biochem Biophys 1997; 337:275-283.
14. Hill JR, Morris DR. Cell-specific translational regulation of S-adeno-sylmethionine decarboxylase mRNA. Dependence on translation and coding capacity of the cis-acting upstream open reading frame. J Biol Chem 1993; 268:726-731.
15. Hossenlopp P, Wells D, Chambon B. Animal DNA-dependent RNA polymerases - Partial purification and properties of three classes of RNA polymerases from uninfected and adenovirus-infected HeLa cells. Eur J Biochem 1975; 58:237-251.
16. Jerina DM. The 1982 Bernard B. Brodie Award Lecture. Metabolism of Aromatic hydrocarbons by the cytochrome P-450 system and epoxide hydrolase. Drug Metab Dispos 1983; 11:1-4.
17. Kim SG, Kim YH. Gender-related expression of rat microsomal epoxide hydrolase during maturation: post-transcriptional regulation. Mol Pharmacol 1992; 42:75-81.
18. Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 1986; 44:283-292.
19. Krowczynska A, Yenofsky R, Brawerman G. Regulation of messenger RNA stability in mouse erythroleukemia cells. J Mol Biol 1985; 181:231-239.
20. Lancaster JM, Brownlee HA, Bell DA, Futreal A, Marks JR, Berchuck A et al. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinogenesis 1996; 17:160-162.
21. Lee SY, Rasheed S. A simple procedure for maximum yield of high-quality plasmid DNA. Biotechniques 1990; 9:676-679.
22. Lu AY, Miwa GT. Molecular properties and biological functions of microsomal epoxide hydrase. Ann Rev Pharmacol Toxicol 1980; 20:513-531.
23. McGlynn KA, Rosvold EA, Lustbader ED, Hu Y, Clapper ML, Zhou T et al. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci USA 1995; 92:2384-2387.
24. Milland J, Christiansen D, Thorley BR, McKenzie IF, Loveland BE. Translation is enhanced after silent nucleotide substitutions in A+T- rich sequences of the coding region of CD46 cDNA. Eur J Biochem 1996; 238:221-230.
25. Nishiyama K, Funai T, Yokota S, Ichiyama A. ATP-dependent degradation of a mutant serine: pyruvate/alanine: glyoxylate aminotransferase in a primary hyperoxaluria type 1 case. J Cell Biol 1993; 123:1237-1248.
26. Oesch F. Significance of various enzymes in the control of reactive metabolites. Arch Toxicol 1987; 60:174-178.
27. Oesch F, Glatt H, Schimassmann H. The apparent ubiquity of epoxide hydratase in rat organs. Biochem Pharmacol 1977; 26: 603-607.
28. Omiecinski CJ, Aicher L, Holubkov R, Checkoway H. Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. Pharmacogenetics 1993; 3:150-158.
29. Omiecinski CJ, Aicher L, Swenson L. Developmental expression of human microsomal epoxide hydrolase. J Pharmacol Exp Ther 1994; 269:417-423.
30. Parkinson A, Thomas PE, Ryan DE, Levin W. The in vivo turnover of rat liver microsomal epoxide hydrolase and both the apoprotein and heme moieties of specific cytochrome P-450 isozymes. Arch Biochem Biophys 1983; 225:216-236.
31. Ross J. mRNA stability in mammalian cells. Microbiol Rev 1995; 59:423-450.
32. Shiraki H, Guengerich FP. Turnover of membrane proteins: kinetics of induction and degradation of seven forms of rat liver microsomal cytochrome P-450, NADPH-cytochrome P-450 reductase, and epoxide hydrolase. Arch Biochem Biophys 1984; 235:86-96.
33. Skoda RC, Demierre A, McBride OW, Gonzalez FJ, Meyer UA. Human microsomal xenobiotic epoxide hydrolase. Complementary DNA sequence, complementary DNA-directed expression in COS-1 cells, and chromosomal localization. J Biol Chem 1988; 263:1549-1554.
34. Smith CAD, Harrison DJ. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997; 350:630-633.
35. Spielberg SP, Gordon GB, Blake DA, Goldstein DA, Herlong HF. Predisposition to phenytoin hepatotoxicity assessed in vitro. N Engl J Med 1981; 305:722-727.
36. Svitkin YV, Cammack N, Minor PD, Almond JW. Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472→U. Virology 1990; 175:103-109.
37. Thomas PE, Ryan DE, von Bahr C, Glaumann H, Levin W. Human liver microsomal epoxide hydrolase. Correlation of immunochemical quantitation with catalytic activity. Mol Pharmacol 1982; 22:190-195.
38. Yamamoto M, Kure S, Engel JD, Hiraga K. Structure, turnover and heme-mediated suppression of the level of mRNA encoding rat liver delta-aminolevulinate synthase. J Biol Chem 1988; 263:15973-15979.